Please assess the completion status of the following clinical trial:

Trial Title: Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Participants already on treatment with DUODOPA (having already concluded the naso-intestinal treatment phase) according to the local DUODOPA product label and to routine clinical care for advanced PD patients~* Participants with available data on DUODOPA treatment, on previous PD conventional treatments and with at least one of the scales/questionnaires under study already collected on the participant's clinical chart~* Participant or legal representative has given written informed consent~* Non-professional caregiver (relative or familiar who give daily assistance to the patient) has given his/her written consent~Exclusion Criteria:~• History or presence of any condition that might interfere with the long-term continuation of the duodenal infusion of DUODOPA

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Participants with Parkinson's disease (Type: None): Participants with advanced levodopa-responsive Parkinson's disease and severe motor fluctuations and hyper-/dyskinesia who were prescribed and treated in accordance with the local levodopa/carbidopa intestinal gel product label

Based on this trial design, predict the completion outcome and termination type (if applicable).